| Market Capitalization (Millions $) |
120 |
| Shares
Outstanding (Millions) |
154 |
| Employees |
1 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-31 |
| Cash Flow (TTM) (Millions $) |
-15 |
| Capital Exp. (TTM) (Millions $) |
0 |
Citius Pharmaceuticals Inc
The Company was formed in the state of Nevada on September 9, 2010 as Trail One,
Inc. On September 12, 2014, we entered into a Share Exchange and Reorganization
Agreement (the "Exchange Agreement"), among Trail One, Inc., Citius
Pharmaceuticals, LLC, a Massachusetts limited liability company ("Citius"),
and the beneficial holders of the membership interests of Citius (the "Citius
Stockholders"). On September 12, 2014, Trail One, Inc. had no assets, no
liabilities, and 5,000,000 shares of issued and outstanding common stock.
Pursuant to the Exchange Agreement, (i) Trail One, Inc. issued 21,625,219 shares
of common stock to the Citius Stockholders, which represented approximately 72.0%
of the outstanding shares of common stock following the closing of the Exchange
Agreement (the "Reverse Acquisition") and the first closing of the Private
Offering described below. The Trail One, Inc. existing shareholders before the
Reverse Acquisition and the first closing of the Private Offering owned 5,000,000
shares of common stock or 16.7% of the outstanding shares of common stock following
the closing of the Exchange Agreement.
Company Address: 11 Commerce Drive Cranford 7016 NJ
Company Phone Number: 967-6677 Stock Exchange / Ticker: NASDAQ CTXR
| CTXR is expected to report next financial results on December 21, 2023. |
|
|
